Targeted epithelial tight junction dysfunction causes immune activation and contributes to development of...

Area of Science:

• Gastroenterology
• Immunology
• Molecular Biology

Background:

• Inflammatory bowel disease (IBD) involves epithelial dysfunction, immune alterations, and microbiota changes.
• Intestinal epithelial myosin light chain kinase (MLCK) activity is implicated in IBD-related barrier dysfunction.
• The specific role of primary epithelial barrier defects in colitis development is unclear.

Purpose of the Study:

• To investigate if primary intestinal epithelial barrier dysfunction can contribute to colitis development.
• To assess the impact of dysregulated epithelial barrier function on mucosal immunity and disease susceptibility.

Main Methods:

• Developed transgenic (Tg) mice with constitutively active MLCK (CA-MLCK) in intestinal epithelia.
• Assessed physiology, immune status, and disease susceptibility in Tg mice compared to non-Tg controls.
• Challenged Tg mice with specific lymphocytes to induce colitis.

Main Results:

• CA-MLCK Tg mice showed significant barrier loss but no spontaneous disease.
• Tg mice exhibited mucosal immune activation, including increased lymphocytes and cytokine production.
• Tg mice developed accelerated and more severe colitis with reduced survival upon immune challenge.

Conclusions:

• Primary epithelial barrier dysfunction is insufficient to cause experimental intestinal disease.
• Barrier defects can broadly activate mucosal immune responses.
• Epithelial barrier dysfunction accelerates the onset and severity of immune-mediated colitis.